Log in

NYSE:DRDDRDGOLD Stock Price, Forecast & News

$16.29
-0.42 (-2.51 %)
(As of 07/13/2020 04:00 PM ET)
Add
Compare
Today's Range
$15.87
Now: $16.29
$16.62
50-Day Range
$9.01
MA: $12.57
$16.76
52-Week Range
$2.84
Now: $16.29
$17.04
Volume487,600 shs
Average Volume523,503 shs
Market Capitalization$1.12 billion
P/E Ratio203.63
Dividend Yield1.35%
Beta0.97
DRDGOLD Limited, a gold mining company, engages in surface gold tailings retreatment business in South Africa. The company's activities include exploration, extraction, processing, and smelting. It recovers gold from surface tailings in the central and western Witwatersrand basin in Gauteng province. The company was founded in 1895 and is headquartered in Rosebank, South Africa.
Read More
DRDGOLD logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.5Community Rank: 2.1Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.05 out of 5 stars


Industry, Sector and Symbol

Industry Gold & silver ores
Sub-IndustryN/A
Previous SymbolNASDAQ:DROOY
CUSIPN/A
Phone27-11-470-2600

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$194.84 million
Cash Flow$0.25 per share
Book Value$2.76 per share

Profitability

Miscellaneous

Employees2,617
Market Cap$1.12 billion
Next Earnings Date9/1/2020 (Estimated)
OptionableOptionable

Receive DRD News and Ratings via Email

Sign-up to receive the latest news and ratings for DRD and its competitors with MarketBeat's FREE daily newsletter.

DRDGOLD (NYSE:DRD) Frequently Asked Questions

How has DRDGOLD's stock been impacted by COVID-19 (Coronavirus)?

DRDGOLD's stock was trading at $6.02 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, DRD stock has increased by 170.6% and is now trading at $16.29. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of DRDGOLD?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for DRDGOLD in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for DRDGOLD.

When is DRDGOLD's next earnings date?

DRDGOLD is scheduled to release its next quarterly earnings announcement on Tuesday, September 1st 2020. View our earnings forecast for DRDGOLD.

How often does DRDGOLD pay dividends? What is the dividend yield for DRDGOLD?

DRDGOLD declared an annual dividend on Tuesday, June 9th. Investors of record on Thursday, June 18th will be given a dividend of $0.1488 per share on Thursday, June 25th. This represents a yield of 3.4%. The ex-dividend date is Wednesday, June 17th. View DRDGOLD's dividend history.

What price target have analysts set for DRD?

1 equities research analysts have issued 1-year target prices for DRDGOLD's stock. Their forecasts range from $11.50 to $11.50. On average, they expect DRDGOLD's stock price to reach $11.50 in the next twelve months. This suggests that the stock has a possible downside of 29.4%. View analysts' price targets for DRDGOLD.

Has DRDGOLD been receiving favorable news coverage?

News stories about DRD stock have been trending very negative this week, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. DRDGOLD earned a news impact score of -3.2 on InfoTrie's scale. They also assigned press coverage about the basic materials company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the near future. View the latest news about DRDGOLD.

Who are some of DRDGOLD's key competitors?

What other stocks do shareholders of DRDGOLD own?

Who are DRDGOLD's key executives?

DRDGOLD's management team includes the following people:
  • Mr. Daniël Johannes Pretorius B.Proc., LLB, CEO & Exec. Director (Age 52)
  • Mr. Adriaan Jacobus Riaan Davel CA (SA), BCom (Hons), M.Com., CFO & Exec. Director (Age 43)
  • Ms. Reneiloe Masemene, Group Legal Counsel, Company Sec. & Prescribed Officer (Age 39)
  • Mr. Wilhelm Jacobus Schoeman BTech Ana, Operations Director of Ergo Mining Operations Proprietary Limited (Age 45)
  • Francois Bouwer, Group Financial Accountant

What is DRDGOLD's stock symbol?

DRDGOLD trades on the New York Stock Exchange (NYSE) under the ticker symbol "DRD."

Who are DRDGOLD's major shareholders?

DRDGOLD's stock is owned by many different institutional and retail investors. Top institutional shareholders include Envestnet Asset Management Inc. (0.02%).

Which institutional investors are selling DRDGOLD stock?

DRD stock was sold by a variety of institutional investors in the last quarter, including Envestnet Asset Management Inc..

How do I buy shares of DRDGOLD?

Shares of DRD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is DRDGOLD's stock price today?

One share of DRD stock can currently be purchased for approximately $16.29.

How big of a company is DRDGOLD?

DRDGOLD has a market capitalization of $1.12 billion and generates $194.84 million in revenue each year. The basic materials company earns $5.53 million in net income (profit) each year or $0.08 on an earnings per share basis. DRDGOLD employs 2,617 workers across the globe.

What is DRDGOLD's official website?

The official website for DRDGOLD is www.drdgold.com.

How can I contact DRDGOLD?

DRDGOLD's mailing address is 1 Sixty Jan Smuts Building 2nd Floor - North Tower 160 Jan Smuts Avenue, Rosebank T3, 2193. The basic materials company can be reached via phone at 27-11-470-2600 or via email at [email protected]

This page was last updated on 7/14/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.